13 July 2023
Ropes & Gray Advises Pfizer on $25m Strategic Investment in CellCentric
Advising firms
Deal team
13 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Brad Flint Lead | Ropes & Gray | Partner | venture capital and emerging companies | Not stated |
| David Dowling Lead | Ropes & Gray | Counsel | strategic transactions | Not stated |
| Sam Wolfe-Murray | Ropes & Gray | Associate | strategic transactions | Not stated |
| Rajarshi Banerjee | Ropes & Gray | Associate | life sciences | Not stated |
| Kyle Connors | Ropes & Gray | Associate | life sciences | Not stated |
| Danielle Heinlein | Ropes & Gray | Associate | life sciences | Not stated |
| Corinne Maguire | Ropes & Gray | Associate | life sciences | Not stated |
| Andrew Howard | Ropes & Gray | Partner | tax | Not stated |
| David Saltzman | Ropes & Gray | Partner | tax | Not stated |
| Ariella Mutchler | Ropes & Gray | Senior associate | Not stated | Not stated |
| Sophie Waters | Ropes & Gray | Associate | Not stated | Not stated |
| Hannah Kerr-Peterson | Ropes & Gray | Associate | life sciences regulatory | Not stated |
| Edward Machin | Ropes & Gray | Associate | data, privacy & cybersecurity | Not stated |
Stated terms
- Stated value
- USD 25m ($25m)
- What the figure measures
- Total transaction value
- Client
- PfizerInvestor
- Counterparties
- CellCentric (Other)